Facial involvement and the severity of psoriasis

Abstract

Background Psoriasis is a chronic, inflammatory skin disorder characterized by welldemarcated erythematous-scaly lesions, affecting 0-6.6% of the world population. Facial lesions are neglected in most descriptions in current literature, although some studies indicate that it could be a predictor of psoriasis severity. Objective To compare the severity of psoriasis, measured by the Psoriasis Area and Severity Index (PASI) and Dermatology Life Quality Index (DLQI), in patients with and without facial lesions.Material and Methods This is a cross-sectional study, whose sample size was 63 individuals for each group. Subjects were included in the HUPES Complex Dermatology Service (Salvador/BA -Brazil) from April 2014 to January 2016. Demographic information was obtained using a prestructured form. Assessments of psoriasis severity and quality of life were done using PASI and DLQI, respectively. Results Facial lesions were detected on 63 (50.0%) of the 126 patients included. The pinna was the most frequently affected region (63.5%). Mean PASI in the group with facial involvement was 14.0 vs. 6.0, when facial involvement was absent. DLQI means for these groups were, respectively, 7.5 and 4.7.Conclusions Facial involvement in a psoriasis patient was a marker of disease severity, and its identification should influence the therapeutic decision.

Applicability of the Geographic Tongue Area and Severity Index among Healthcare Professionals: A Cross-Sectional Clinical Validation of a Newly Developed Geographic Tongue Scoring System

“…Similar to the PASI, the newly proposed GTASI exhibited good reliability criteria in assessing GT, suggesting that it is a first-choice indexing instrument for determining the severity, clinical definition and follow-up of GT lesions [ 30 , 31 ]. Several studies support the reliability of the PASI because it provides an acceptable level of correlation and agreement in assessing psoriasis, even though it may be affected by differences in its interpretation [ 25 , 31 , 32 , 33 , 34 , 35 ].…”

Facial psoriasis in a mask-like distribution

“…Approximately 50% of psoriasis patients attending psoriasis clinics have facial involvement. 3,5,6 Facial involvement is more common in younger individuals and those with a higher mean Psoriasis Area Severity Index (PASI). 3 Thus, facial psoriasis may be considered a marker of disease severity.…”

Precision therapy for psoriasis patients

“…Элементы сыпи на волосистой части головы, складках кожи, ладонноподошвенной областях относятся к «проблемной локализации» и ассоциированы с резистентным к лечению вариантом болезни [48]. Высыпания на лице -прогностические факторы тяжелого течения псориаза [48,49].…”